April 19, 2023
The Patent Trial and Appeal Board has rejected biotechnology company Streck's contention that nearly 30 claims in a Ravgen genetic testing patent are obvious or anticipated, siding with the patent owner in yet another challenge to the testing system it had used to score $272 million in infringement damages in underlying litigation.
January 19, 2023
Pfizer is set to tell a Connecticut federal court next week that communications between its lawyers and the FBI shouldn't be disclosed in its trade secrets suit accusing former executives of stealing diabetes and cancer medication research. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.